Skip to main content
. 2024 Jun 18;183(9):3877–3883. doi: 10.1007/s00431-024-05645-w

Table 2.

Summary of questionnaire findings amongst Dutch pediatricians on FH care in children

Question Pediatricians
n = 158
Awareness

  FH familiarity rated ≥ 4—n (%)

  Aware of FH guidelines—n (%)

  Aware of lipid disorder health institutes—n (%)

111 (70.3)

83 (52.5)

127 (80.4)
Knowledge

  Correctly defined FH—n (%)

  Correctly identified FH lipid profile—n (%)

  Correctly identified FH prevalence—n (%)

  Correctly identified FH transmission rate to first-degree relatives—n (%)

  Correctly identified that genetic testing is not required for an FH diagnosis—n (%)

  Correctly identified CVD risk in untreated FH patients—n (%)

  Correctly identified age of premature CVD in males—n (%)

  Correctly identified age of premature CVD in females—n (%)

112 (70.9)

121 (76.6)

44 (27.8)

101 (63.9)

72 (45.6)

42 (26.6)

9 (5.7)

6 (3.8)
Practice

  Assesses family history of CAD in children with a myocardial or cerebral infarction—n (%)

  Screens lipid profile in close relatives of children with FH—n (%)

  Performs screening for hypercholesterolemia in children in families with premature CAD, age group:

158 (100.0)

101 (63.9)
    0–6 years—n (%) 25 (15.8)
    7–12 years—n (%) 106 (67.1)
    13–18 years—n (%) 15 (9.5)
     Unknown—n (%) 12 (7.6)
  Has referred children to health institutes for lipid disorders (when aware of them)—n (%) 83 (65.4)
  Prescribes statin monotherapy in case of hypercholesterolemia—n (%) 97 (61.4)
  Prescribes statin and ezetimibe in case of severe hypercholesterolemia—n (%) 67 (42.4)
Preference

  Consider pediatricians for early screening and detection of FH in children—n (%)

  Prefers an alarming comment to lipid profiles at risk for FH—n (%)

60 (38.0)

130 (82.3)

CVD cardiovascular disease, CAD coronary artery disease, FH familial hypercholesterolemia, no. number, IQR interquartile range